Tech Company Financing Transactions
DioGenix Funding Round
DioGenix, based in Bethesda, secured $3.2 million from private investors.
Transaction Overview
Company Name
Announced On
12/5/2013
Transaction Type
Venture Equity
Amount
$3,200,000
Round
Undisclosed
Investors
Proceeds Purpose
The financing will support the completion of the largest prospective clinical diagnostic trial of its kind in MS.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3 Bethesda Metro Center 700
Bethesda, MD 20814
USA
Bethesda, MD 20814
USA
Phone
Website
Email Address
Overview
DioGenix develops and commercializes non-invasive diagnostic and prognostic treatment response monitoring tests.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Larry Tiffany
Chief Financial Officer
Richard Vincent
Chief Scientific Officer
Eric Eastman
Browse more venture capital transactions:
Prev: 12/5/2013: Trufa venture capital transaction
Next: 12/5/2013: Juno Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We document funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs